Heat-shock transcription factor (HSF)-1 pathway required for Caenorhabditis elegans immunity
See allHide authors and affiliations
-
Edited by Frederick M. Ausubel, Harvard Medical School, Boston, MA, and approved July 11, 2006 (received for review May 16, 2006)

Abstract
Innate immunity comprises physical barriers, pattern-recognition receptors, antimicrobial substances, phagocytosis, and fever. Here we report that increased temperature results in the activation of a conserved pathway involving the heat-shock (HS) transcription factor (HSF)-1 that enhances immunity in the invertebrate Caenorhabditis elegans. The HSF-1 defense response is independent of the p38 MAPK/PMK-1 pathway and requires a system of chaperones including small and 90-kDa inducible HS proteins. In addition, HSF-1 is needed for the effects of the DAF-2 insulin-like pathway in defense to pathogens, indicating that interacting pathways control stress response, aging, and immunity. The results also show that HSF-1 is required for C. elegans immunity against Pseudomonas aeruginosa, Salmonella enterica, Yersinia pestis, and Enterococcus faecalis, indicating that HSF-1 is part of a multipathogen defense pathway. Considering that several coinducers of HSF-1 are currently in clinical trials, this work opens the possibility that activation of HSF-1 could be used to boost immunity to treat infectious diseases and immunodeficiencies.
Increased temperature promotes expression of heat-shock (HS) proteins (HSPs) that are found in high levels in almost all inflammatory diseases (1). However, the precise mechanism by which increased temperature mediates innate immunity is not clear. The nematode Caenorhabditis elegans, which has evolved an immune system to recognize pathogens and respond accordingly (2–4), provides an excellent compromise between complexity and genetic tractability to dissect innate immunity pathways activated by heat stress.
A hallmark of C. elegans immunity is activation of defense responses through a conserved p38 MAPK pathway. As in mammalian innate immunity, the p38 MAPK signaling pathway is required for proper C. elegans defense against the human opportunistic pathogen Pseudomonas aeruginosa, which is the major cause of death in cystic fibrosis patients and immunocompromised individuals (5, 6). The pathway also is required to elicit an apoptotic response to Salmonella enterica in the C. elegans germline (7) and for defense to Bacillus thuringiensis toxin Cry5B (8). Based on the fact that C. elegans does not have NF-κB-like transcription factors and that the p38 MAPK pathway seems to be more ancient than NF-κB (9, 10), it has been postulated that the p38 MAPK pathway is the ancestral immune pathway of a common ancestor of insects, nematodes, and vertebrates (11, 12).
Although MAPKs have been involved in mammalian defense response and activation of HSPs (13–15), it was unknown whether HSPs and HS transcription factor (HSF)-1 function downstream of the MAPK-mediated immune responses. Here we report that activation of a conserved pathway involving HSF-1 triggers C. elegans immunity to bacterial pathogens. We demonstrate that both small and 90-kDa HSPs activated in an HSF-1-dependent manner are effectors responsible for the immune response. Our results show that the HSF-1 pathway regulates immunity independently of p38 MAPK and that it interacts with an insulin-like pathway that includes the insulin-like growth factor receptor DAF-2 and the forkhead transcription factor DAF-16. We provide direct evidence that HSF-1-regulated proteins are effectors of the DAF-2/DAF-16 pathway required for pathogen resistance.
Results and Discussion
HS Elicits C. elegans Immunity Independently of SEK-1/MAPKK.
To study the role of HSPs in C. elegans defense response and their relationship with MAPKs, we first examined whether HS impacts C. elegans susceptibility to P. aeruginosa. After HS, wild-type N2 animals were exposed to P. aeruginosa by using slow-killing conditions (16) and death of animals on P. aeruginosa-containing plates was scored over the course of infection. The time required for 50% of the nematodes to die (TD50) under these conditions was calculated in three independent experiments. HS-treated wild-type animals exhibited higher resistance (TD50 = 53.5 ± 3.35 h) to P. aeruginosa-mediated killing than animals not exposed to HS (TD50 = 42.5 ± 2.87 h) as shown in Fig. 1 A. In mammals, the p38 MAPK signaling pathway is activated by various cytotoxic stresses (13–15), including HS. Therefore, we analyzed whether the NSY-1 MAPKKK/SEK-1 MAPKK/PMK-1 p38 MAPK pathway, which is crucial for C. elegans protection against P. aeruginosa (5, 6), is involved in the HS-mediated protection to the pathogen. Because PMK-1 activation requires SEK-1 (5), sek-1(ag1) mutants were exposed to mild HS or left untreated and were then exposed to the pathogen to address whether the kinase was involved in the HS-mediated protection to P. aeruginosa infection. As shown in Fig. 1 B, HS-treated sek-1(ag1) mutants were more resistant to P. aeruginosa than untreated animals, indicating that HS-mediated protection is independent of SEK-1 activation. Although PMK-1 may also function independently of SEK-1 as a downstream target of MEK-1 in pathogen resistance (6), active PMK-1 was not observed in sek-1(ag1) mutants before or after HS (data not shown).
HS enhances C. elegans immune response against P. aeruginosa in a SEK-1-independent manner. (A) Wild-type N2 animals untreated or HS-treated were exposed to P. aeruginosa PA14 (P < 0.005). (B) Wild-type, sek-1(ag1) (P < 0.0001), and sek-1(ag1) HS-treated animals (P = 0.954) were exposed to P. aeruginosa. (C) sek-1(ag1) animals untreated or HS-treated were exposed to live E. coli OP50 (P < 0.002). (D) sek-1(ag1) animals untreated or HS-treated also were exposed to heat-killed E. coli (P > 0.1). For each condition, 40–50 animals were used. (E) Immunological detection of Hsp90 in untreated control (C) and HS-treated wild-type or sek-1(ag1) animals. Detection of actin is used as a loading control.
By using transgenic animals carrying additional hsp-70 gene copies, it was found that HS increases the life span of Drosophila melanogaster (17) and C. elegans (18). In addition, animals overexpressing HSF exhibit an extended life span of ≈40% (19). Based on these results and on the short life span of sek-1(ag1) mutants on plates containing Escherichia coli (TD50 = 36 ± 7.2h) (Fig. 1 C), it is conceivable to postulate that HS may protect against bacterial infection by improving the general fitness of the animals rather than specifically boosting their immune system. However, under certain conditions, E. coli OP50 kills C. elegans (20), and proliferating E. coli OP50 is a cause of death (21). In addition, sek-1(ag1) animals are more rapidly killed by live E. coli than by killed E. coli, and HS treatment increases the protection of sek-1(ag1) animals against live E. coli (TD50 = 126.2 ± 8.2 h vs. TD50 = 36 ± 7.2 h) (Fig. 1 C). These results, together with life-span experiments (5) using 5-fluoro-2′-deoxyuridine, which prevents transcription in both prokaryotes and eukaryotes, indicate that sek-1(ag1) nematodes are immunocompromised animals killed by live, replicating bacteria. Consistent with the idea that HS boosts defense response but not the overall fitness of the animals, the survival of wild-type animals grown on live or killed E. coli is not further enhanced by the HS treatment used in this study (Fig. 5, which is published as supporting information on the PNAS web site). Hsp90, which is up-regulated in mammalian systems upon HS and used as a marker of HSF activity, was found to be up-regulated by HS in a HSF-1-dependent manner (Fig. 6, which is published as supporting information on the PNAS web site) and independent of SEK-1 (Fig. 1 E), raising the possibility that HSF-1 may be involved in a SEK-1-independent defense response against live bacteria.
HS-Mediated Immunity to P. aeruginosa Requires HSF-1.
To test the hypothesis that HSF-1 is involved in a SEK-1-independent immunity to P. aeruginosa, we studied whether HSF-1 was involved in defense to the pathogen. The protection against P. aeruginosa by HS was not observed in hsf-1 RNAi animals, which also appear to be more susceptible to the pathogen under control conditions (Fig. 2 A), indicating that HSF-1 activity is required not only for HS-meditated protection but also for defense to P. aeruginosa-mediated killing under nonstressful conditions. The increased susceptibility to P. aeruginosa of animals lacking HSF-1 was confirmed by using the hsf-1(sy441) mutant, which carries a single G→A mutation that results in the truncation of the last 86 aa of HSF-1 and in the elimination of HS-induced expression of hsp-16.2 (22) (Fig. 2 B). As shown in Fig. 2 C, hsf-1 RNAi animals are more susceptible to P. aeruginosa than control animals when the infections are performed at 20°C, which is a more conducive temperature for animals lacking HSF-1.
HSF is required for C. elegans immunity to P. aeruginosa. (A) Wild-type worms grown on E. coli carrying a vector control were untreated or HS-treated and exposed to P. aeruginosa (P < 0.03). In addition, wild-type animals grown on E. coli expressing hsf-1 double-stranded RNA were untreated or HS-treated and exposed to P. aeruginosa (P = 0.2660). hsf-1 RNAi animals were more susceptible to P. aeruginosa compared with vector RNAi controls (P < 0.005). (B) Wild-type or hsf-1(sy441) animals were grown on E. coli carrying a vector control and exposed to P. aeruginosa (P < 0.0001). (C) Wild-type animals grown on vector control or hsf-1 double-stranded RNA were exposed to P. aeruginosa at 20°C (P < 0.0001). (D) Wild-type or CF1824 (hsf-1 overexpression) animals were exposed to P. aeruginosa (P < 0.001). (E) Wild-type animals grown on E. coli carrying a vector control or expressing pmk-1 double-stranded RNA were exposed to P. aeruginosa (P < 0.0001). (F) hsf-1(sy441) animals grown on E. coli carrying a vector control or expressing pmk-1 double-stranded RNA were exposed to P. aeruginosa (P = 0.0023). For each condition, 80–200 animals were used.
The requirement of HSF-1 for HS-mediated immunity to P. aeruginosa (Fig. 2 A–C) suggests that animals exhibiting higher activity of HSF-1 would then be better protected from P. aeruginosa-mediated killing than wild-type animals. As shown in Fig. 2 D, animals overexpressing hsf-1 were significantly more resistant to P. aeruginosa infection than wild-type animals. Consistent with the idea that HSF-1 is involved in SEK-1-independent immunity to P. aeruginosa, Fig. 2 E and F shows that PMK-1 and HSF-1 function synergistically in the activation of immunity to P. aeruginosa. These results demonstrate that HSF-1 is involved in SEK-1-independent immunity to P. aeruginosa and suggest that HSPs may be required for protection.
A System of Chaperones Mediates HSF-1-Dependent Immunity.
To address whether HSPs play a role in C. elegans defense to P. aeruginosa, we used RNAi to target HSP-encoding genes whose promoters contain HSF-1-binding elements and that are known to be heat-inducible (19, 23, 24). The results shown in Table 1 demonstrate that RNAi ablation of Hsp90/DAF-21 and members of the Hsp16 family increases susceptibility to P. aeruginosa, indicating that these HSPs are required for full immunity. Given the sequence similarity among members of the Hsp16 family, we cannot rule out the possibility of cross-RNAi. In addition, we cannot rule out the possibility of redundancy or incomplete RNAi when no RNAi phenotypes were detected. RNAi ablation of the HSPs required for C. elegans immunity diminished the increased resistance to P. aeruginosa of animals overexpressing hsf-1 (Table 1) and did not enhance the increased susceptibility to P. aeruginosa of the hsf-1(sy441) mutant (Fig. 7, which is published as supporting information on the PNAS web site), suggesting that these HSPs may act downstream HSF-1. Taken together, these results indicate that HSF-1 regulates a system of chaperones that is required for proper innate immunity to P. aeruginosa. The statistically significant but modest effect that suppression of individual HSPs has on immunity (Table 1) is consistent with the idea that a network of chaperones is required for the HSF-1 effects on aging and immunity. RNAi inhibition of individual HSPs has no significant effects on the life span of wild-type animals and has modest effects on long-lived mutants (25). Furthermore, several HSPs appear to be required for proper antigen presentation (26).
HSPs are required for C. elegans immunity to P. aeruginosa
HSF-1 Is Required for the Immune Function of the DAF-2/DAF-16 Pathway.
The DAF-2/DAF-16 pathway, whose role in life span has been very well established (27), has recently been shown to regulate aging and age-related diseases through small HSPs and other genes (19). DAF-16 is a forkhead transcription factor that regulates a wide variety of genes involved in longevity, stress response, metabolism, and development (28–30), is positively regulated by HS (19) and negatively regulated by DAF-2 (31). In addition, it has been shown that mutations in daf-16 suppress the pathogen-resistant phenotype of daf-2(e1370) mutants (32). As previously shown, daf-2(e1370) mutants were resistant to P. aeruginosa (32) (Fig. 3 A), and daf-16::gfp animals, which carry additional daf-16 gene copies, also were found to be more resistant to the pathogen, as expected (Fig. 3 B). Both daf-2(e1370) and daf-16::gfp nematodes showed higher levels of HSP90 than wild-type animals (Fig. 3 F), suggesting that a higher activity of HSF-1 may be in part responsible for the increased resistance of these animals to P. aeruginosa. Enhanced resistance of daf-2(e1370) and daf-16::gfp animals to P. aeruginosa was reduced by the RNAi inhibition of hsf-1 (Fig. 3 C and D). In addition, HS protection is not seen in daf-16 RNAi animals (Fig. 3 E). This reduction of the enhanced resistance phenotype of daf-2(e1370) and daf-16::gfp animals by RNAi ablation of hsf-1 provides evidence that HSF-1-regulated proteins may be effectors of the DAF-2/DAF-16 pathway required for pathogen resistance.
The enhanced resistance phenotype of daf-2(e1370) and daf-16::gfp animals to P. aeruginosa requires HSF-1 activity. (A and B) Wild-type, daf-2(e1370) (P < 0.0001), and daf-16::gfp (P < 0.0001) animals were exposed to P. aeruginosa. (C) daf-2(e1370) grown on E. coli carrying a vector control or expressing hsf-1 double-stranded RNA were exposed to P. aeruginosa (P < 0.0001). (D) daf-16::gfp grown on E. coli carrying a vector control or expressing hsf-1 double-stranded RNA were exposed to P. aeruginosa (P < 0.0001). (E) Wild-type animals grown on E. coli expressing daf-16 double-stranded RNA were untreated or HS-treated and exposed to P. aeruginosa (P > 0.1). For each condition, 80–100 animals were used. (F) Immunological detection of Hsp90 in WT, daf-2(e1370), and daf-16::gfp animals.
HSF-1 Is Part of a Multipathogen Defense Pathway.
To study whether HSF-1 is part of an immune response specific to P. aeruginosa or whether it is required for immunity to pathogens in general, we infected C. elegans with Yersinia pestis (33), S. enterica (34, 35), and Enterococcus faecalis (20), as previously described. Fig. 4 A–C shows that hsf-1 RNAi animals are more susceptible to the three pathogens studied. In addition, ablation of hsf-1 expression by RNAi reduced the enhanced resistance to Y. pestis, S. enterica, and En. faecalis exhibited by daf-2(e1370) animals (Fig. 4 A–C), indicating that the HSF-1 is required for immunity to Gram-negative and Gram-positive bacteria.
HSF-1 is required for immunity to Gram-negative and Gram-positive pathogens. (A) Wild-type worms grown on E. coli carrying a vector control or on E. coli expressing hsf-1 double-stranded RNA were exposed to Y. pestis KIM5 (P < 0.0001). daf-2(e1370) worms grown on E. coli carrying a vector control or on E. coli expressing hsf-1 double-stranded RNA were exposed to Y. pestis KIM5 (P < 0.001). (B) Wild-type worms grown on E. coli carrying a vector control or on E. coli expressing hsf-1 double-stranded RNA were exposed to S. enterica SL1344 (P < 0.0001). daf-2(e1370) worms grown on E. coli carrying a vector control or on E. coli expressing hsf-1 double-stranded RNA were exposed to S. enterica SL1344 (P < 0.0001). (C) Wild-type worms grown on E. coli carrying a vector control or on E. coli expressing hsf-1 double-stranded RNA were exposed to En. faecalis OG1RF (P < 0.0001). daf-2(e1370) worms grown on E. coli carrying a vector control or on E. coli expressing hsf-1 double-stranded RNA also were exposed to En. faecalis OG1RF (P < 0.0001). (D) HSF-1 activated by HS and the DAF-2/DAF-16 pathway enhances C. elegans immunity. HSF-1 mediates protection via induction of Hsp90 and small HSPs in a PMK-1 independent manner.
Conclusions
Fever is an ancient immune mechanism used by metazoans in response to microbial infections. Although homeotherms are capable of internally increasing the body temperature, poikilotherms migrate toward warmer environments to increase their temperature in response to infections. The activation of the HSF-1 pathways by HS and its function in C. elegans immunity provides a molecular explanation for the beneficial role of behavioral fevers in poikilotherms. It will be interesting to study whether C. elegans responds to pathogen infections by migrating toward warmer areas to activate HSF-1-mediated immune responses.
Taken together, our results show that a conserved pathway involving HSF-1 contributes to C. elegans immunity to bacterial pathogens. HSF-1 acts downstream of DAF-2/DAF-16 in defense response and confers protection through a system of HSPs independently of the p38 MAPK pathway (Fig. 4 D). At this point in our investigation, we cannot distinguish whether HSF-1 is part of a constitutive immune response or whether it is activated by pathogens. Initial attempts to address whether pathogens activate HSF-1 proved inconclusive, which is not surprising given the wide number of potential roles in the organism that could be played by HSF-1. Pathogens may lead to HSF-1 activation in only a subset of C. elegans cells that cannot be detected in whole-animal lysates. HSF-1 and the chaperone system may directly or indirectly regulate the expression of innate immunity genes. Another possibility is that the chaperone system may be required for recognition and degradation of bacterial virulence factors or for the proper folding of effector molecules of the immune system. The results presented here suggest that therapeutics aiming to boost the innate immune system through the activation of the HSF-1 pathway could be developed to treat bacterial infections.
Materials and Methods
Bacterial and Nematode Strains.
The E. coli OP50 (36), P. aeruginosa PA14 (16), S. enterica SL1344 (37), Y. pestis KIM5 (38), En. faecalis OG1RF (39) strains were used. C. elegans strains used were wild-type N2, sek-1(ag1), hsf-1(sy441), daf-2(e1370), daf-16::gfp [zIs356 (pDAF-16::DAF-16-GFP;rol-6)], and CF1824 [muEx265 (HSF-1p::HSF-1 cDNA + myo-3::GFP)].
C. elegans Killing Assay.
C. elegans wild-type N2 animals and mutants were maintained as hermaphrodites at 15°C, grown on modified nematode growth medium (NGM) agar plates, and fed with E. coli strain OP50 as described (36). E. coli, P. aeruginosa, and S. enterica cultures were grown in Luria–Bertani (LB) broth at 37°C. Y. pestis cultures were grown at 25°C. Bacterial lawns used for C. elegans killing assays were prepared by spreading 20 μl of an overnight culture of the bacterial strains on modified NGM agar (0.35% instead of 0.25% peptone) in plates 3.5 cm in diameter. Infections with En. faecalis OG1RF were performed as described in ref. 20. Briefly, En. faecalis liquid cultures were grown in brain–heart infusion broth at 37°C and plated on brain–heart infusion agar supplemented with 50 μg/ml gentamicin. Plates were incubated at 25°C for 12 h before seeding them with young adult nematodes grown at 15°C. The killing assays were performed at 25°C unless otherwise indicated, and animals were scored and transferred twice a day to fresh plates. Animals were considered dead when they failed to respond to touch.
RNAi.
We used the RNA interference technique to generate loss-of-function RNAi phenotypes by feeding worms with E. coli expressing double-stranded RNA that is homologous to a target gene (40, 41). Briefly, E. coli strain HT115(DE3) harboring the appropriate vectors were grown in LB broth containing 100 μg/ml ampicillin and 10 μg/ml tetracycline at 37°C overnight. Bacteria were plated onto NGM plates containing 100 μg/ml ampicillin and 10 mM isopropyl β-d-thiogalactoside and were allowed to grow overnight at 37°C.
Gravid adults were allowed to lay eggs on RNAi-expressing lawns of bacteria for 5 h. The eggs were allowed to develop into young adults on RNAi or vector control plates at 15°C. Under these conditions, hsf-1 RNAi does not result in the developmental arrest observed when animals are grown at 25°C. Young adult animals grown under these conditions were HS-treated or untreated and subsequently transferred to P. aeruginosa-containing plates. Bacteria strains expressing double-stranded RNA to inactivate the C. elegans genes were obtained from Wellcome/Cancer Research (Cambridge, U.K.) and Open Biosystems (Huntsville, AL). The identity of the clones was confirmed by sequencing.
HS Treatment.
Animals on NGM plates were given HS at 32°C in a water bath for 2 h and either used directly for protein preparation or allowed to recover at 25°C for 4 h before exposure to pathogen. As a control, animals on NGM plates were maintained at 15°C before exposure to pathogen. We found no significant difference between animals subjected to two insults at the same time (shift from 15°C to 25°C and exposure to the pathogen) and animals subjected to the two insults sequentially (shift from 15°C to 25°C and, after 4 h, exposure to the pathogen) (data not shown).
Statistical Analyses.
Animal survival was plotted as a nonlinear regression curve with the PRISM 4.00 computer program. Survival curves are considered significantly different from the control when P < 0.05. Prism uses the product limit or Kaplan–Meier method to calculate survival fractions and the logrank test, which is equivalent to the Mantel–Heanszel test, to compare survival curves.
Immunological Detection of Proteins.
Whole-worm lysates were prepared in the presence of protease inhibitors. Hsp90 was detected with a monoclonal antibody from Stressgen Biotechnology (San Diego, CA) and enhanced chemiluminesence approach. Actin was detected by using a polyclonal antibody from Sigma (St. Louis, MO). Multiple experiments were done, and the data presented are from representative experiments.
Acknowledgments
We thank Richard Morimoto for helpful discussions about our data, Joseph Heitman for critical reading of the manuscript, and the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN) for all of the strains used in this study. A.A. receives funding from the Whitehead Scholars Program, the Duke Center for Translational Research, the Southeast Regional Center of Excellence for Biodefense and Emerging Infections, and National Institutes of Health Grants GM070977 and AI065641.
Footnotes
- *To whom correspondence should be addressed at: Department of Molecular Genetics and Microbiology, Duke University Medical Center, Box 3054 DUMC, Durham, NC 27710. E-mail: a.aballay{at}duke.edu
-
Author contributions: A.A. and V.S. designed research; V.S. performed research; A.A. and V.S. analyzed data; and A.A. and V.S. wrote the paper.
-
Conflict of interest statement: No conflicts declared.
-
This paper was submitted directly (Track II) to the PNAS office.
- Abbreviations::
- HS,
- heat shock;
- HSF-1,
- HS transcription factor-1;
- HSP,
- HS protein;
- NGM,
- nematode growth medium.
- © 2006 by The National Academy of Sciences of the USA
References
- ↵
-
↵
- Mylonakis E. ,
- Aballay A.
- ↵
- ↵
-
↵
- Kim D. H. ,
- Feinbaum R. ,
- Alloing G. ,
- Emerson F. E. ,
- Garsin D. A. ,
- Inoue H. ,
- Tanaka-Hino M. ,
- Hisamoto N. ,
- Matsumoto K. ,
- Tan M. W. ,
- Ausubel F. M.
-
↵
- Kim D. H. ,
- Liberati N. T. ,
- Mizuno T. ,
- Inoue H. ,
- Hisamoto N. ,
- Matsumoto K. ,
- Ausubel F. M.
- ↵
-
↵
- Huffman D. L. ,
- Abrami L. ,
- Sasik R. ,
- Corbeil J. ,
- van der Goot F. G. ,
- Aroian R. V.
- ↵
-
↵
- Mochida Y. ,
- Takeda K. ,
- Saitoh M. ,
- Nishitoh H. ,
- Amagasa T. ,
- Ninomiya-Tsuji J. ,
- Matsumoto K. ,
- Ichijo H.
- ↵
- ↵
- ↵
- ↵
-
↵
- Han J. ,
- Lee J. D. ,
- Bibbs L. ,
- Ulevitch R. J.
-
↵
- Tan M. W. ,
- Mahajan-Miklos S. ,
- Ausubel F. M.
- ↵
- ↵
-
↵
- Hsu A. L. ,
- Murphy C. T. ,
- Kenyon C.
-
↵
- Garsin D. A. ,
- Sifri C. D. ,
- Mylonakis E. ,
- Qin X. ,
- Singh K. V. ,
- Murray B. E. ,
- Calderwood S. B. ,
- Ausubel F. M.
-
↵
- Garigan D. ,
- Hsu A. L. ,
- Fraser A. G. ,
- Kamath R. S. ,
- Ahringer J. ,
- Kenyon C.
-
↵
- Hajdu-Cronin Y. M. ,
- Chen W. J. ,
- Sternberg P. W.
- ↵
-
↵
- GuhaThakurta D. ,
- Palomar L. ,
- Stormo G. D. ,
- Tedesco P. ,
- Johnson T. E. ,
- Walker D. W. ,
- Lithgow G. ,
- Kim S. ,
- Link C. D.
-
↵
- Morley J. F. ,
- Morimoto R. I.
- ↵
- ↵
- ↵
- ↵
-
↵
- Lee S. S. ,
- Kennedy S. ,
- Tolonen A. C. ,
- Ruvkun G.
- ↵
-
↵
- Garsin D. A. ,
- Villanueva J. M. ,
- Begun J. ,
- Kim D. H. ,
- Sifri C. D. ,
- Calderwood S. B. ,
- Ruvkun G. ,
- Ausubel F. M.
- ↵
- ↵
- ↵
-
↵
- Brenner S.
- ↵
-
↵
- Une T. ,
- Brubaker R. R.
-
↵
- Murray B. E. ,
- Singh K. V. ,
- Ross R. P. ,
- Heath J. D. ,
- Dunny G. M. ,
- Weinstock G. M.
- ↵
- ↵